33
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Incidence of and risk factors for diabetic retinopathy in diabetic clinic attenders

, PhD, , PhD, , MPH & , MD, FRCP
Pages 309-325 | Accepted 07 Dec 2000, Published online: 05 Nov 2015

References

  • Dwyer MS, Melton LJ III, Ballard DJ, Palumbo PJ, Trautmann JC, Chu CP. Incidence of diabetic retinopathy and blindness: A population-based study in Rochester, Minnesota. Diabetes Care. 1985; 8:316–22.
  • Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care. 1978; 1:168–99.
  • Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiology study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984 102:527–32.
  • Sorsby A. The incidence and causes of blindness in England and Wales 1963–1968. Report on Public Health and Medical Subjects No. 114. London: HMSO, 1971.
  • Keen H. Prevalence of blindness in diabetics. Roy Coll Phys London. 1972; 7:53–60.
  • Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy ETDRS Report No. 9. Ophthalmology. 1991; 98:766–85.
  • Klein R, Moss SE, Klein BEK, Davis MD, DeMets DL. The Wisconsin epidemiology study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology. 1989; 96:1501–10.
  • Diabetes Control and Complications Trial (DCCT): Update. Diabetes Care. 1990; 13:427–33.
  • DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991; 90:450–1.
  • Yanko L, Golbourt U, Michaelson IC, Shapiro A, Yaari S. Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol. 1983; 67:759–65.
  • Ballard DJ, Melton LJ III, Dwyer MS, Trautmann JC, Chu CP, O'Fallon WM, Palumbo PJ. Risk factors for diabetic retinopathy: A population-based study in Rochester, Minnesota. Diabetes Care. 1986; 9:334–42.
  • Borch-Johnsen K, Nissen H, Henriksen E, Kreiner S, Sailing N, Deckert T, et al. The natural history of insulin-dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabetic Med. 1987; 4:201–10.
  • Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. New Engl J Med. 1984; 311:365–72.
  • Lee ET, Lee VS, Kingsley RM, Lu M, Russell D, Asat NR, et al. Diabetic retinopathy in Oklahoma Indians with NIDDM: Incidence and risk factors. Diabetes Care. 1992; 15:1620–7.
  • Foulds WS, McCuish A, Barrie T, Green F, McClure E, Barker JH. Diabetic retinopathy in the West of Scotland: its detection and prevalence, and the cost-effectiveness of a proposed screening programme. Health Bull (Edinb). 1983; 41:318–26.
  • Kohner EM, Aldington SJ, Nugent Z. Retinopathy at entry in the United Kingdom Prospective Diabetes Study (UKPDS) of maturity onset diabetes. Diabetes. 1987; 36(Suppl. I): 42A.
  • Janghorbani M, Jones RB, Allison SP. Incidence of and risk factors for cataract among diabetic clinic attenders. Ophthalm Epidemiol. 2000; 7:13–25.
  • Janghorbani M, Jones RB, Allison SP. Incidence of and risk factors for proliferative retinopathy and association with blindness among diabetic clinic attenders. Ophthalm Epidemiol. 2000; 7:225.
  • Jones RB, Hedley A J, Peacock I, Allison SP, Tattersall RB. A computer-assisted register and information system for diabetes. Methods Inform Med. 1983; 22:4–14.
  • Jones RB, Gregory R, Jones EW, Kerr D, Allison SP, Mcleod A, et al. The quality and relevance of peripheral neuropathy data on a diabetic clinical information system. Diabetic Med. 1992; 9:934–7.
  • Jones RB, Hedley AJ. A computer in the diabetic clinic: completeness of data in a clinical information system for diabetes. Pract Diabetes. 1986 3:295–6.
  • Norusis MJ. SPSS for Windows Base System User's Guide Release 6.0. Chicago, Illinois, 1993.
  • Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22:719–48.
  • Lee ET. Statistical methods for survival data analysis. New York: Wiley, 1992: 104–30.
  • Cox DR. Regression models and life table. Roy Statist Soc. 1977; 34:187–220.
  • Kaplan LJ, Meier P. Nonparametric estimation from incomplete observation. Am Statist Assoc. 1958; 53:457–81.
  • Gardner MJ, Altman DG. Statistics with confidence. London: British Medical Association, 1989.
  • Hurwitz B, Yudkin J. Diabetes care: whose responsibility? Br Med J. 1984; 289:1000–1.
  • Jones RB, Hedley AJ, Gale E. Identification of diabetic patients treated with insulin or oral hypoglycaemics within a defined population. Comm Med. 1986; 8: 104–10.
  • Stephenson J, Fuller JH. Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study. Diabetologia. 1994; 37:278–85.
  • Moss SE, Klein R, Kessler SD, Richie KA. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology. 1985; 92:62–7.
  • Kinyoun JL, Martin DC, Fujimoto WY, Leonetti DL. Ophthalmoscopy versus fundus photography for detecting and grading diabetic retinopathy. Invest Ophthalmol Vis Sci. 1992; 33:1888–93.
  • Harding SP, Broadbent DM, Neoh C, White MC, Vora J. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetes & eye disease study. Br Med J. 1995; 311: 1131–5.
  • Kornerup T. Studies in retinopathy An investigation of 1000 cases of diabetes. Acta Med Scand. 1955 37:81–101.
  • Balodimos MC, Aiello LM, Gleason RE. Retinopathy in mild diabetes of long duration. Arch Ophthalmol. 1969; 81:660–6.
  • Nilsson SE, Nilsson JE, Frostberg E. The Kristanstad Survey. 11 Studies in a representative adult control group. Acta Med Scand Suppl. 1967; 409:1–42.
  • West KM, Erdreich J, Stober JA. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes. 1980; 29:501–8.
  • Newell SW, Tolbert B, Bennett J, Parsley TL. The prevalence and risk of diabetic retinopathy among Indians of Southwest Oklahoma. J Oklahoma State Med Assoc. 1989; 82:414–24.
  • Klein R, Klein BEK, Moss SE, Davis M, DeMets D. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984; 102:520–6.
  • University Group Diabetes Program. A study of the effect of hypoglycaemic agents on vascular complications in patients with adult onset diabetes. Diabetes. 1982; 31 (Suppl. 5): 1–81.
  • The Kroc Collaborative Study Group. Diabetic retinopathy after two years of intensified insulin treatment: follow-up of the Kroc Collaborative study. J Am Med Assoc. 1988; 260:37–41.
  • Lauritzen T, Frost Larsen K, Larsen HW, Deckert T. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin- dependent diabetics. Lancet. 1983; 1:200–4.
  • Lauritzen T, Frost Larsen K, Larsen HW, Deckert T, Steno study Group. Ten years experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes. 1985; 34 (Suppl.3)74–9.
  • Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O, Aker Diabetes Group. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J. 1985; 290:811–15.
  • Dahl-Jorgenson K, Brinchmann-Hanson O, Hanssen KF, Ganes T, Kierulf P, Smeland E, et al. Effect of near normoglycaemic for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: the Oslo Study. Br Med J. 1986; 293:1995–9.
  • Beck-Nielson H, Rickleson B, Mogenson CE, Olsen T, Ehlers N, Nielson CB, et al. Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM. Diabetes Care. 1985; 8:585–9.
  • Doft BH, Kingsley LA, Orchard TJ, Kuller L, Drash A, Becker D. The association between long-term diabetic control and early retinopathy. Ophthalmology. 1984; 91:763–9.
  • Howard Williams J, Hillson RM, Bron A, Audry P, Mann JI, Hockaday TDR. Retinopathy is associated with higher glycaemia in maturity-onset type diabetes. Diabetologia. 1984; 27:198–202.
  • Nathan DM, Singer DE, Godine DE, Hodgson-Harrington C, Perlmutter C. Retinopathy in older type II diabetics. Association with glucose control. Diabetes. 1986; 35:797–801.
  • Teuscher A, Schnell H, Wilson PWF. Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care. 1988; 11:246–51.
  • Chase HP, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O'Brien D. Glucose control and the renal and retinal complications of insulin-dependent diabetes. J Am Med Assoc. 1989; 261:1155–60.
  • Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. Glycosylated haemoglobin predicts the incidence and progression of diabetic retinopathy. J Am Med Assoc. 1988; 260:2864–71.
  • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med. 1993; 329:977–86.
  • Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Interventions Study (SDIS) after 5 years. J Intern Med. 1991; 230:101–8.
  • Klein R. Diabetes retinopathy. Ann Rev Publ Health. 1996; 17:137–58.
  • Lioyo CE, Becker B, Eilis D, Orchard TJ. Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis. Am J Epidemiol. 1996; 143:431–41.
  • Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomised prospective 6-year study. Diabetes Res Clin Pract. 1995; 28:103–17.
  • UKPDS Group. UK Prospective Diabetes Study 17: a nine-year update of a randomised, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996; 124:136–45.
  • UKPDS Group. UK Prospective Diabetes Study 33. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998 352: 837–53.
  • Oakley WG, Pyke DA, Tattersall RB, Watkins PJ. Long term diabetes. Quart J Med. 1974; 43:145–56.
  • Knowler WC, Bennet PH, Ballantine EJ. Increased incidence of retinopathy in diabetics with elevated blood pressure. New Engl J Med. 1980; 302:645–50.
  • Kalter-Leibovici O, Van Dyk DJ, Leibovici L, Loya N, Erman A, Kremer I, et al. Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes. 1991; 40:204–10.
  • Mitchell P. Development and progression of diabetic eye disease in Newcastle (1977–1984): rates and risk factors. Austr NZ J Ophthalmol. 1985; 13:39–44.
  • Jerneld B, Algvere P. Proteinuria and blood glucose levels in a population with diabetic retinopathy. Am J Ophthalmol. 1987; 104:283–9.
  • Paetkau ME, Boyd TAS, Winship B, Grace M. Cigarette smoking and diabetic retinopathy. Diabetes. 1977; 26:46–9.
  • West KM, Erdreich LS, Stober JA. Absence of a relationship between smoking and diabetic microangiopathy. Diabetes Care. 1980; 3:250–2.
  • Rabb MF, Gagliano DA, Sweeney HE. Diabetic retinopathy in blacks. Diabetes Care. 1990; 13:1202–6.
  • Moss SE, Klein R, Klein BEK. Association of cigarette smoking with diabetic retinopathy. Diabetes Care. 1991; 14:119–26.
  • Klein R, Klein BEK, Davis MD. Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol. 1983; 118:228–38.
  • Barnett AH, Britton JR, Leatherdale BA. Study of possible risk factors for severe retinopathy in non-insulin-dependent diabetes. Br Med J. 1983; 287:529.
  • Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of diabetic retinopathy study (DRS) findings. DRS report number 8. Ophthalmology. 1981; 88:583–600.
  • Blankenship GW. Fifteen-year argon laser and xenon photocoagulation results of Bascom Palmer Eye Institute's patients participating in the diabetic retinopathy study Ophthalmology. 1991;98:125–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.